Alice Claire Noel Brown

This inventor holds 11 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Psioxus Therapeutics Limited, Akamis Bio Limited. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alice Claire Noel Brown. Retrieved from https://idiyas.com/inventor/alice-claire-noel-brown

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 25(Granted Patents)

Location History:

Oxfordshire, GB (2018 - 2024)
Abingdon, GB (2021 - 2024)

Company Filing History:

8 out of 22

Psioxus Therapeutics Limited

Years Active: 2018-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12653852 - Oncolytic adenoviruses armed with heterologous genes (2026-06-16),

2. 11970536 - Group B adenovirus encoding an anti-TCR-complex antibody or fragment (2024-04-30),

3. 11938159 - Oncolytic adenoviruses armed with heterologous genes (2024-03-26),

4. 11439678 - Oncolytic adenoviruses armed with heterologous genes (2022-09-13),

5. 11155622 - Virus encoding an anti-TCR-complex antibody or fragment (2021-10-26),

6. 10849945 - Oncolytic adenovirus encoding a B7 protein or active fragment (2020-12-01),

7. 10548929 - Oncolytic adenovirus encoding a therapeutic protein or active fragment (2020-02-04),

8. 10472648 - Method of making adenovirus and corresponding plasmids (2019-11-12),

9. 10124028 - Oncolytic adenovirus encoding a B7 protein or active fragment (2018-11-13),

10. 10034905 - Group B adenovirus modified in the E4orf4 region (2018-07-31),

11. 9987314 - Oncolytic adenoviruses armed with heterologous genes (2018-06-05),

Title: The Innovative Contributions of Alice Claire Noel Brown

Introduction

Alice Claire Noel Brown is a distinguished inventor based in Oxfordshire, GB, renowned for her significant contributions to the field of oncolytic virotherapy. With a remarkable portfolio of 10 patents, her work is paving the way for innovative cancer treatments and therapeutic advancements.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Group B adenovirus encoding an anti-TCR-complex antibody or fragment." This patent discusses a replication-deficient oncolytic viral vector or capable group B oncolytic adenovirus selected from Ad11 and enadenotucirev. The invention encodes an antibody or a binding fragment for expression on the surface of a cancer cell, specifically targeting the CD3 protein of a T-cell receptor complex (TCR). Notably, the virus does not encode a B7 protein or any active fragment, highlighting its specificity and potential in pharmaceutical applications, particularly in cancer treatment. Another recent patent she developed involves oncolytic adenoviruses armed with heterologous genes, further showcasing her commitment to advancing cancer therapeutics.

Career Highlights

Alice has had an impactful career, with her expertise being harnessed by esteemed organizations such as Psioxus Therapeutics Limited and Akamis Bio Limited. Her innovative approaches and strategic insights have made significant contributions to the research and development of viral vectors in treating cancer.

Collaborations

Throughout her illustrious career, Alice has collaborated with prominent colleagues including Brian Robert Champion and Kerry David Fisher. These partnerships have enriched her research endeavors and propelled her innovations in the field of oncolytic virotherapy.

Conclusion

Alice Claire Noel Brown stands as a pioneering inventor in the realm of oncolytic therapies, driving forward the development of cutting-edge treatments for cancer. With her extensive patent portfolio and collaborative spirit, she continues to inspire new avenues of research and innovation in the medical field.

Profile summary based on public USPTO records.